Medicated Skin Care in Belgium
Many products in medicated skin care are not considered crucial by consumers or face competition from reimbursed Rx products. Thus, sales of medicated skin care were affected directly by the economic crisis that hampered self-medication in this category in 2011 and consumers subsequently watching their budgets more closely. Moreover, the information campaigns regarding the danger of mycosis and other skin complaints, which began during the first half of the review period, were less effective in...
Euromonitor International's Medicated Skin Care in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International's Medicated Skin Care in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Medicated Skin Care market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
Table 3 Medicated Skin Care Company Shares by Value 2007-2011
Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
Table 5 Hair Loss Treatments Brand Shares by Value 2008-2011
Table 6 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
Table 7 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Laboratoria Qualiphar NV SA in Consumer Health (belgium)
Strategic Direction
Key Facts
Summary 1 Qualiphar NV SA, Laboratoria: Key Facts
Summary 2 Qualiphar NV SA, Laboratoria: Operational Indicators
Company Background and Production
Competitive Positioning
Summary 3 Qualiphar NV SA, Laboratoria: Competitive Position 2011
Tilman NV SA in Consumer Health (belgium)
Strategic Direction
Key Facts
Summary 4 Tilman NV SA: Key Facts
Summary 5 Tilman NV SA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 6 Tilman NV SA: Competitive Position 2011
Executive Summary
Slight But Fragile Recovery in 2011
Negative Environment for Consumer Health Affects Sales
Disparate Results in A Still Fragmented Competitive Environment
Distribution Remains Under the Control of Pharmacies Despite Some Changes
Bleak Prospects Overall
Key Trends and Developments
Fragile Economic Recovery To Result in A Temporary Improvement
Authorities and Medical Experts Blow Hot and Cold
More Health & Wellness, Certainly, But Also More Realism
Remedies for Increasingly Stressful Lifestyles
Brand Equity To Remain the Key in A Restricted Environment
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 9 Life Expectancy at Birth 2006-2011
Market Data
Table 10 Sales of Consumer Health by Category: Value 2006-2011
Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 12 Consumer Health Company Shares 2007-2011
Table 13 Consumer Health Brand Shares 2008-2011
Table 14 Penetration of Private Label by Category 2006-2011
Table 15 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 16 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 17 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements - Registration and Classification
Switch Climate
Self-medication and Preventative Medicine
Generics
Switches
Summary 7 OTC - Switches 2009-2011
Sources
Summary 8 Research Sources
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
Table 3 Medicated Skin Care Company Shares by Value 2007-2011
Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
Table 5 Hair Loss Treatments Brand Shares by Value 2008-2011
Table 6 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
Table 7 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Laboratoria Qualiphar NV SA in Consumer Health (belgium)
Strategic Direction
Key Facts
Summary 1 Qualiphar NV SA, Laboratoria: Key Facts
Summary 2 Qualiphar NV SA, Laboratoria: Operational Indicators
Company Background and Production
Competitive Positioning
Summary 3 Qualiphar NV SA, Laboratoria: Competitive Position 2011
Tilman NV SA in Consumer Health (belgium)
Strategic Direction
Key Facts
Summary 4 Tilman NV SA: Key Facts
Summary 5 Tilman NV SA: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 6 Tilman NV SA: Competitive Position 2011
Executive Summary
Slight But Fragile Recovery in 2011
Negative Environment for Consumer Health Affects Sales
Disparate Results in A Still Fragmented Competitive Environment
Distribution Remains Under the Control of Pharmacies Despite Some Changes
Bleak Prospects Overall
Key Trends and Developments
Fragile Economic Recovery To Result in A Temporary Improvement
Authorities and Medical Experts Blow Hot and Cold
More Health & Wellness, Certainly, But Also More Realism
Remedies for Increasingly Stressful Lifestyles
Brand Equity To Remain the Key in A Restricted Environment
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 9 Life Expectancy at Birth 2006-2011
Market Data
Table 10 Sales of Consumer Health by Category: Value 2006-2011
Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 12 Consumer Health Company Shares 2007-2011
Table 13 Consumer Health Brand Shares 2008-2011
Table 14 Penetration of Private Label by Category 2006-2011
Table 15 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 16 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 17 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements - Registration and Classification
Switch Climate
Self-medication and Preventative Medicine
Generics
Switches
Summary 7 OTC - Switches 2009-2011
Sources
Summary 8 Research Sources
